Stock comparison
Jeena Sikho Lifecare Limited
JSLL.BO$73.75BHealthcare Market cap, Sector
Anbio Biotechnology
NNNN$708.4MHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
JSLL.BO 51 NNNN
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.BO5wins
1winsNNNN
84B
D58
87A
A87
92A
A89
66C
A95
75B
F36
91A
B73
95A
B72
Side-by-side metrics
| Metric | JSLL.BO | NNNN |
|---|---|---|
| Market cap | Winner: $73.75B | $708.4M |
| P/E (TTM) | Winner: 33.2x | 171.9x |
| EV/EBIT | Winner: 24.1x | 212.9x |
| ROIC (TTM) | Winner: 39.15% | 21.48% |
| Gross margin | Winner: 88.58% | 87.06% |
| Net margin | 27.68% | 73.75% Winner |
| Revenue CAGR 5y | Winner: 57.81% | 18.21% |
| EPS CAGR 5y | Winner: 86.67% | 58.42% |
| Debt / Equity | 0.3x | - Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.BO leads on
- Market cap$73.75Bvs $708.4M+99%
- EV/EBIT24.1xvs 212.9x+89%
- P/E (TTM)33.2xvs 171.9x+81%
- Revenue CAGR 5y57.81%vs 18.21%+69%
NNNN leads on
- Debt / Equity-vs 0.3x+100%
- Net margin73.75%vs 27.68%+62%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.